The management of cervical dysplasia in pregnant individuals focuses on maintaining maternal well-being while considering pregnancy-related factors. Risk-based colposcopy should be performed with an immediate CIN 3+ risk threshold of ≥4% or with other significant high-risk screening results. Testing for HPV is recommended for individuals aged 30 years and older and for postpartum surveillance of abnormal cases in those aged 25 years and older. The impact of financial support on postpartum medical care can influence the necessity of colposcopy during pregnancy. It is important to note that there are specific challenges with performing colposcopy during pregnancy and there needs to be judicious use of ectocervical biopsy. Excisional procedures are reserved for confirmed or likely invasive disease. In cases of cervical cancer, the involvement of specialized medical practitioners is advised. Postpartum management strategies involving colposcopy and expedited loop electrosurgical excision procedures underscore the significance of risk-based evaluations. In summary, the case provides comprehensive insights into managing cervical dysplasia during and after pregnancy, focusing on evidence-based guidelines and multidisciplinary collaboration for optimal outcomes.